Clinical Trial Update: Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized study comparing whole-brain radiation therapy alone to erlotinib given with WBRT as first-line treatment in patients with non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Multiple Brain Metastases, Non-small-cell Lung Cancer | Phase 3 | Status: COMPLETED